Bill Colston

Bill Colston is an experienced life science entrepreneur and executive with a significant background in biotechnology and genomics. Here are some key details about his career and background:

Professional Experience

Bill Colston currently serves as the Chief Executive Officer of CS Genetics, a privately held genomics technology company.1 He was appointed to this role in September 2024.

Prior to joining CS Genetics, Bill has founded and led several notable companies in the biotech sector:

• He founded QuantaLife, where he pioneered the invention of droplet digital PCR (ddPCR) technology and served as CEO until the company's acquisition by Bio-Rad.1
• He also founded Sestina Bio, a synthetic biology company.12
• Additionally, he founded HealthTell, a diagnostics firm.12

Academic and Research Background

Bill Colston holds impressive academic credentials:

• B.Sc. in Molecular Biology from the University of Texas at Austin
• Ph.D. in Biomedical Engineering from the University of California, Davis1

Earlier in his career, Bill directed the U.S. biologic and chemical defense R&D program at Lawrence Livermore National Laboratory.1

Advisory Roles

Bill has served on numerous private and public boards throughout his career.1 He is also active as an advisor and Executive in Residence at the University of California, San Francisco.2

Expertise and Contributions

Bill Colston is recognized as a biotech innovator with over 30 years of experience in developing cutting-edge technologies.2 His work has primarily focused on areas such as digital biology, genomics, and biotechnology. His expertise in these fields has led to significant advancements, particularly in the development of tools for scientific discovery, molecular diagnostics, and the creation of new vaccines and therapeutics.